BrainsWay GAAP EPS of $0.12, revenue of $32.64M (NASDAQ:BWAY)
BrainsWay (BWAY) reported 1H GAAP EPS of $0.12 and revenue of $32.64M, up 35.0% Y/Y. As of June 30, 2026, the company had $62.4M in cash and an accumulated deficit of $85.8M. Shares rose 1.51%.
How this was made
The 30-second read
Why it matters
The earnings surprise and revenue growth provide a modest catalyst for the stock.
Market read
Small-cap earnings release with modest upside potential.
What to watch
Cash balance decline and accumulated deficit could weigh on longer-term sentiment.
Background
BrainsWay released its first-half 2026 financial results.
Ticker impact
1H GAAP EPS of $0.12 and revenue of $32.64M, up 35% YoY, disclosed in the press release.
potential modest upside as the market prices in better-than-expected earnings.
The numbers are better than prior guidance and the stock rose 1.51% on the news.
Market effects
Limited impact on the broader neurostimulation sector.
Primarily affects US-listed small-cap investors.
Minimal global relevance.
Counterpoint
The earnings beat may be already priced in, limiting upside.
Key entities
- CompanyBrainsWay
Neurostimulation device maker listed on NASDAQ.
